Live from the NIH registry
Studies recruiting near Grand Prairie right now
Top 25 of 1,933 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Texas Oncology DFW — Dallas, Texas (14.1 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Arlington Research Center, Inc. — Arlington, Texas (6.1 mi)
· Sponsor: Takeda
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
North Texas Endocrine Center — Dallas, Texas (14.1 mi)
· Sponsor: Novo Nordisk A/S
Prospective Evaluation of Treatment for Clubfoot
Clubfoot Deformity
N/A
Observational 2,500 participants sought
Texas Scottish Rite Hospital for Children — Dallas, Texas (14.1 mi)
· Sponsor: Texas Scottish Rite Hospital for Children
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
NEXT Oncology Dallas — Irving, Texas (9.7 mi)
· Sponsor: Astellas Pharma Inc
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Primary Open Angle Glaucoma, Open Angle Glaucoma
N/A
Interventional 129 participants sought
Glaucoma Associates of Texas — Dallas, Texas (14.1 mi)
· Sponsor: Sanoculis Ltd
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Phase 1, Phase 2
Interventional 460 participants sought
Texas Oncology - DFW ( Site 8000) — Fort Worth, Texas (17.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Dallas, Texas (14.1 mi)
· Sponsor: Avenzo Therapeutics, Inc.
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
Paralysis; Quadriplegic
N/A
Interventional 2 participants sought
UT Southwestern Medical Center — Dallas, Texas (14.1 mi)
· Sponsor: Nader Pouratian
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
Baylor University Medical Center — Dallas, Texas (14.1 mi)
· Sponsor: Nurix Therapeutics, Inc.
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
Angiokeratomas
Phase 2
Interventional 15 participants sought
Epiphany Dermatology — Southlake, Texas (18.8 mi)
· Sponsor: Palvella Therapeutics, Inc.
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Ut Southwestern — Dallas, Texas (14.1 mi)
· Sponsor: Cook Research Incorporated
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Epic Medical Research — Red Oak, Texas (17.2 mi)
· Sponsor: Novartis Pharmaceuticals
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
Baylor University Medical Center — Dallas, Texas (14.1 mi)
· Sponsor: Synairgen Research Ltd.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Epic Medical Research - DeSoto — DeSoto, Texas (11.7 mi)
· Sponsor: Crystalys Therapeutics
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Cancer, Tumor, Solid
Phase 1, Phase 2
Interventional 168 participants sought
NEXT Dallas — Irving, Texas (9.7 mi)
· Sponsor: OncoResponse, Inc.
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Dallas, Texas (14.1 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina of North Texas — Dallas, Texas (14.1 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
Amyotrophic Lateral Sclerosis (ALS)
Phase 2
Interventional 60 participants sought
VA North Texas Health Care System — Dallas, Texas (14.1 mi)
· Sponsor: Dallas VA Medical Center
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjögren, Sjogren Disease
Phase 1
Interventional 36 participants sought
Cullinan Investigative Site — Plano, Texas (29.6 mi)
· Sponsor: Cullinan Therapeutics Inc.
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Phase 2, Phase 3
Interventional 740 participants sought
Corxel Investigational Site — Dallas, Texas (14.1 mi)
· Sponsor: Corxel Pharmaceuticals
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
US Oncology Investigational Product Center (IPC) — Irving, Texas (9.7 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
University of Texas Southwestern — Dallas, Texas (14.1 mi)
· Sponsor: Steba Biotech S.A.
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
UT Southwestern Medical Center — Dallas, Texas (14.1 mi)
· Sponsor: University of Texas Southwestern Medical Center
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Knee Cartilage Defects
Phase 3
Interventional 300 participants sought
Zenos Clinical Research — Dallas, Texas (14.1 mi)
· Sponsor: Medipost, Inc.